Stop Forced Organ Harvesting Act of 2025
Latest action (May 8, 2025) — Received in the Senate and Read twice and on Foreign Relations.
What it does
Congressional Research Service, Feb 21, 2025This bill requires the President to impose sanctions on persons (individuals and entities) involved in forced organ trafficking and authorizes the Department of State to deny or revoke the passports of individuals convicted of certain crimes related to organ trafficking.
Specifically, the President must report to Congress a list of persons that facilitate (1) forced organ harvesting, or (2) trafficking in persons for organ harvesting. For each person on the list, the President must impose property- and visa-blocking sanctions.
Furthermore, the State Department may deny or revoke the passport of an individual who has been convicted of a federal crime of knowingly transferring any human organ for valuable consideration for use in human transplantation, if the individual (1) is subject to imprisonment or supervised release resulting from that conviction, and (2) used a passport or crossed an international border when committing that crime.
Face Value
as passed the HouseHow much of this bill its name accounts for.
- Every bill starts at100
- Nothing counted against it: one area of law, and short enough that length doesn't register.
Face Value measures reach, not honesty. A big bill can be accurately named, and a low score is not an accusation — it means the contents reach further than any short title could describe. Count it yourself ↗ How this is worked out
What Congress did
1 recordedOn decisive vote
House · May 7, 2025
A fast-track vote: no amendments, short debate, and two thirds needed to pass. Used for bills expected to be uncontroversial.
Who lobbied on this
3 organizationsThese organizations told Congress, in their own quarterly disclosures, that they were lobbying on this bill.
- Merck & Co., Inc.no position stated
“…the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program. H.R. 1503/S. 2916, Prescription Information Modernization Act of 2023 H.R. 1968, Full-Year Continuing Appropriations and Extensions Act, 2025 S. 1040,…” filing ↗
- Sanofi US Services Incno position stated
“…HR 1503: Prescription Information Modernization Act of…” filing ↗
- Viatris Inc.no position stated
“…Act H.R. 1843 - Increasing Transparency in Generic Drug Applications Act S. 775 - Increasing Transparency in Generic Drug Applications Act HR1503/S. 2916, Prescription Information Modernization Act Medicaid Generics Penalty Implementation of the Inflation Reduction Act S. 2129 Ensuring…” filing ↗
Most filings say only that an organization lobbied on a bill, not which side it took — where that's the case we say so rather than guessing. Quotes are verbatim from the filing. How this is built.
Discussion
0 commentsSign in to join the discussion and put your vote on the record.
No comments yet. Be the first to make the case.